First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma
Clinical trial NCT03287310 · COMPLETED
Trial details
- NCT number
- NCT03287310
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2019-07-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.